The Sample Taken Before Sydney Was Won: Peres Jepchirchir's EPO Suspension and the Women's Marathon Ledger

August 30, 2026, the finish line of the Sydney Marathon. Peres Jepchirchir ran alone — more than three minutes clear of her Kenyan compatriot Irene Chepet Cheptai. The clock stopped at two hours, 18 minutes and 31 seconds. Sydney had become the seventh World Marathon Major in 2026, and its first women's title went to the reigning Olympic and world champion. That result is now in question. The Athletics Integrity Unit has provisionally suspended the 33-year-old after an out-of-competition sample tested positive for EPO. The sample was collected in Kenya, before the Sydney race. A sample taken before the win, an announcement made after it — the entire sequence of the case turns on that single date.

At Kalinga Stadium I was the only woman in the mixed zone, and the only one listening for the second story — the one that never makes the scoreboard. That habit is doing the work today. The second story here is that the sample which caught Jepchirchir was not collected in a stadium but on a morning in a training camp. The same system that tracks an athlete everywhere was already present before she won.

EPO, or erythropoietin, is a natural substance produced in the kidneys that stimulates the creation of new red blood cells. Injected, it raises the number of oxygen-carrying red blood cells in the bloodstream — which, in sporting terms, means fatigue arrives later. In a marathon, fatigue is the exact thing an athlete has to break in order to win. EPO's defining feature is that it remains detectable in urine or blood for only a short window. That window is the centre of this case.

Jepchirchir's career reads like a textbook: she broke the women's half-marathon world record in 2026 and broke it three more times in 2026. She won the Olympic women's marathon at Tokyo 2026, then returned to the same city in September 2026 to win the World Championships marathon. Add the New York Marathon in 2026, Boston in 2026 and London in 2026 — four majors, plus Sydney. Few women's marathon runners have ever held such a solid inventory: Olympic gold, a world title and four majors, all under one name. That is why this is not an ordinary doping case. It collides with an era of women's marathon running that has barely been written yet.

The margin in Sydney — over three minutes — is a statement by itself. In marathon running, three minutes is not normal. It is the gap that tells you an athlete stood a category above the field. In my coverage ledger I always split that kind of altitude into two parts: the capacity, and the structure that fed the capacity.

In Malappuram, a 51.46 that nobody filed still lived in the fan park — I logged that in 2026, and the principle holds. Until Sydney, Jepchirchir's name was written in four letters: wins. Now two more letters have been added, and the whole career has split in two — before Sydney, and after.

Here I have to state the central point plainly, without handing both sides equal weight. The AIU's provisional suspension is a process, not a verdict. Under the rules, the athlete has the right to have the B sample tested and to a hearing, and until that process concludes, a positive test does not establish guilt. But it is equally true that an out-of-competition sample plus EPO's short detection window, placed side by side, look less like a laboratory error and more like the predictable output of a surveillance design. Catching it is hard; therefore those who are caught are not all of those who are there. That does not weaken the investigation — it exposes its limits, and no athlete's character should be sealed without knowing those limits.

Now the heaviest page in my ledger. Kenyan distance running is an economy in which money passes through many hands: appearance fees and prize money from a new major like Sydney, advances from private management companies, bills for European training camps, and the cost of the family left at home. For elite marathoners, a large share of income comes from the very win now under question. A provisional suspension means the Sydney prize, the Sydney ranking points and the sponsorships attached to Sydney all freeze on paper. One line from one sample can put an athlete's economic life into deep freeze, and the process runs for months regardless of how it ends.

There is another layer inside Kenya that I have watched for years. Kenyan women runners often enter the orbit of an academy or a management agent while still teenagers, and they rarely have the institutional protection that American or European athletes get from a federation. Medical advice, nutrition, sleep, checking the banned list — all of it becomes a personal responsibility. So when a 33-year-old Olympic champion is caught, I cannot stop asking who was around her, who wrote down the name of the injection, and who declined to challenge that advice. That question does not lighten responsibility; it places responsibility where it belongs.

This is where I step off the consensus swing. In doping cases, the habit of giving both sides equal space sounds gracious but renders the decision meaningless. Facts arrive in three separate categories: disputed, unproven, and true. What is true here is that an out-of-competition sample was collected before Sydney, that it is reported positive for EPO, and that the AIU imposed a provisional suspension. What is unproven is whether this is a pattern or a single event. What is disputed is whether technical factors could play a role. Putting all three on the same scale is not reporting; it is laziness.

The most important part of this affair is the part on which nobody is being quoted. The Sydney Marathon was moving into its first edition after gaining seventh-major status in 2026. What is the most valuable asset a new major can buy? A champion with a big name. Jepchirchir was built for that role — Olympic and world champion both. There is no better casting card for a new major's marketing, which is why this news is also a balance-sheet story for the race organisers, not only an athletics story. That is the angle sports journalism usually skips, because the athlete is visible and the event's brand is not.

The stat sheet ends where the athlete's body begins. Jepchirchir's body has been spent across four continents in five years — Tokyo's heat, Boston's hills, London's stone, New York's bridge and Sydney's coastal route. A marathon is a race in which the body's entire history stands up at once. I do not need a biomechanics lab to understand that; I only need to watch how a 33-year-old recovers within two months, and who pays for that recovery. The recovery bill lands with the physiotherapist, and the physiotherapist's bill often comes out of the athlete's own pocket. This is where I keep returning, and I think this is where the next generation's trust will either be built or broken.

Seen from India, the case does not feel distant. The country's women's middle- and long-distance running runs on a system where a government job quota provides stability and state cash awards provide lift, while medical support and monitoring capacity stay thin. On Kerala's tracks I have seen fourth-place finishers paying for their own treatment. When an athlete has no doctor, advice arrives from outside — and nobody keeps the books on advice that arrives from outside. This is not an accusation. It is a reminder that protection is expensive, and where it is absent, ethical decisions are dumped on the athlete alone.

Now the ledger ahead. The B sample and the hearing will take months, and three things will hang in the meantime. First, the September 2026 Tokyo world title — will it carry a mark, or do the suspension dates precede it? Second, Sydney's first women's crown, currently held by a name whose sample was collected before the win. Third, the institutional side of Kenyan marathon running that has faced the fewest questions in the past decade: oversight of training camps and audits of medication records.

I have kept this ledger since 2026, and every year the same question returns to some desk or another: whose sport is it? This case will not be settled quickly, and I do not think it should be. But one thing ought to be settled now — the next time a woman wins on a road like Sydney by three minutes, her recovery room, her physio and her medical records should be as public as her finishing time. Until that ledger opens, we will see every victory twice: once through the clock, and once through doubt.